Thiazole in the targeted anticancer drug discovery

Cancer is known as one of the main causes of death in the world; and many compounds have been synthesized to date with potential use in cancer therapy. Thiazole is a versatile heterocycle, found in the structure of many drugs in use as well as anticancer agents. This review provides an overview of recent advances in thiazole-bearing compounds as anticancer agents with particular emphasis on their mechanism of action in cancerous cells. Chemical designs, structure-activity relationships and relevant preclinical properties have been comprehensively described.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Future medicinal chemistry - 11(2019), 15 vom: 18. Aug., Seite 1929-1952

Sprache:

Englisch

Beteiligte Personen:

Ayati, Adileh [VerfasserIn]
Emami, Saeed [VerfasserIn]
Moghimi, Setareh [VerfasserIn]
Foroumadi, Alireza [VerfasserIn]

Links:

Volltext

Themen:

Anticancer agents
Antineoplastic Agents
Cancer
Cyclin-Dependent Kinases
Drug discovery
EC 2.7.10.1
EC 2.7.11.22
ErbB Receptors
Journal Article
Research Support, Non-U.S. Gov't
Review
Signaling pathways
Thiazole
Thiazoles
Tumor cells

Anmerkungen:

Date Completed 20.05.2020

Date Revised 20.05.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.4155/fmc-2018-0416

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM299264629